Učitavanje...
A T-cell–directed chimeric antigen receptor for the selective treatment of T-cell malignancies
Options for targeted therapy of T-cell malignancies remain scarce. Recent clinical trials demonstrated that chimeric antigen receptors (CARs) can effectively redirect T lymphocytes to eradicate lymphoid malignancies of B-cell origin. However, T-lineage neoplasms remain a more challenging task for CA...
Spremljeno u:
| Izdano u: | Blood |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Hematology
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4543231/ https://ncbi.nlm.nih.gov/pubmed/26056165 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-02-629527 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|